We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Advanced NMR Analysis Helps to Fine-tune Cell Culture Growth Conditions

By LabMedica International staff writers
Posted on 20 Jul 2011
Print article
Image: Cell culture media samples can be rapidly analyzed to provide unequivocal results (Photo courtesy of Claire England, Kapler Communications).
Image: Cell culture media samples can be rapidly analyzed to provide unequivocal results (Photo courtesy of Claire England, Kapler Communications).
Biotech researchers can optimize cell culture-growth conditions by sending samples of culture-growth media for sophisticated nuclear magnetic resonance (NMR) analysis that can identify metabolites that are consumed and beneficial or toxic products that are produced.

The “Spedia-NMR” NMR analysis service is provided by Spinnovation (Nijmegen, The Netherlands). The analysis service identifies a wide selection of feed components, metabolites, and toxic compounds in culture media. By comparing media profiles from different cell culture batches, Spedia-NMR identifies how a cell consumes and metabolizes the media along the culture process. Investigators usually receive results within five working days.

Spedia-NMR was designed to perform rapid, high throughput analyses of cell culture media batches and feed-batches in a very cost-efficient manner, using fully automated sample analysis and data processing. The technology - which has been successfully applied to cell types as varied as CHO (Chinese hamster ovary), stem cells, and virus production platforms - is available to all biotech investigators on a fee-for-sample basis or as a contract service.

Dr. Frederic Girard the CEO of Spinnovation said, “In the short term, Spedia-NMR will fill the gap in knowledge to strengthen and speed up cell-culture development and upstream processing… clients need to know what is going on in their cell culture and they need to know it fast. In the mid-term we will be able to provide methods and tools to our clients to help them to cope with the demand of FDA edicts regarding Quality by Design (QbD) and validation in the production environment.”

Related Links:
Eurofins Spinnovation Analytical B.V


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Isothermal Amplification Technology
SIBA
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.